PANORAMIC view of World’s largest COVID study
Study involving 10,000 patients will investigate a range of potentially ground-breaking oral antivirals
Read More
Tag: Oxford University
Novavax joins Oxford mix-and-match COVID-19 vaccine study in adolescents
The Phase II clinical trial will include at least 360 adolescents aged 12-16 years old
Read More
‘Mix and match’ COVID-19 vaccine study yields promising results
Mixing different vaccines produces a strong immune response against virus, according to researchers
Read More
UK and EU regulators reaffirm the safety of AZ/Oxford Uni’s COVID-19 vaccine
MHRA and EMA conclude the vaccine’s benefits continue to outweigh risks
Read More
WHO panel recommends AZ/Oxford’s COVID-19 vaccine
WHO’s SAGE panel backs wide use of jab in adults, including in people aged over 65
Read More
EU authorisation for AstraZeneca’s COVID-19 vaccine
Jab authorised for use in individuals aged 18 years and older
Read More
AstraZeneca/Oxford University’s COVID-19 vaccine set for UK rollout
Shot was approved by MHRA on 30 December
Read More
AZ/Oxford University’s COVID-19 vaccine shows average efficacy of 70%
Effectiveness ranges from 62% to 90% depending on dosing regimen
Read More
AZ resumes trial of COVID-19 vaccine
The move follows a green light by the UK’s MHRA
Read More
Dexamethasone cut deaths by 35% in ventilated COVID-19 patients
The steroid drug significantly reduced deaths in hospitalised patients with severe respiratory complications
Read More
Gov’t streams £84m into UK COVID-19 vaccines research
The move comes as Oxford Uni and AZ sign a global licensing deal for their vaccine candidate
Read More
Over 50s COVID-19 trial launches across UK
PRINCIPLE is looking at whether existing drugs can be repurposed for older patients in the community who show signs of the disease
Read More
- UKHSA and ICL confirm variant which plays key role in global surge of Strep A infections
- Study reveals heart failure device could monitor patients and prevent hospitalisation
- MIT’s new MRI brain light-detecting technique could support brain cell studies
- PharmaTimes MSEA and NIEA awards are open for entry
- BBSRC invests £48m in Babraham Institute to advance lifelong health research
